BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,149,025 | -24.2% | 83,440 | -8.6% | 0.05% | -22.0% |
Q2 2023 | $4,157,076 | +310.4% | 91,244 | +384.9% | 0.06% | +181.0% |
Q3 2022 | $1,013,000 | -62.8% | 18,816 | -55.6% | 0.02% | -69.1% |
Q2 2022 | $2,723,000 | -17.2% | 42,398 | 0.0% | 0.07% | +1.5% |
Q1 2022 | $3,288,000 | -9.6% | 42,398 | 0.0% | 0.07% | -4.3% |
Q4 2021 | $3,639,000 | +27.9% | 42,398 | +19.9% | 0.07% | +18.6% |
Q3 2021 | $2,845,000 | -0.1% | 35,373 | 0.0% | 0.06% | +1.7% |
Q2 2021 | $2,848,000 | -4.5% | 35,373 | 0.0% | 0.06% | -18.3% |
Q1 2021 | $2,983,000 | +5.1% | 35,373 | 0.0% | 0.07% | -2.7% |
Q4 2020 | $2,838,000 | -0.2% | 35,373 | 0.0% | 0.07% | -20.7% |
Q3 2020 | $2,845,000 | -6.6% | 35,373 | 0.0% | 0.09% | -27.0% |
Q2 2020 | $3,046,000 | +6.1% | 35,373 | 0.0% | 0.13% | -15.4% |
Q1 2020 | $2,872,000 | -24.3% | 35,373 | -21.8% | 0.15% | -22.4% |
Q4 2019 | $3,793,000 | +15.8% | 45,236 | +21.2% | 0.19% | +22.3% |
Q3 2019 | $3,276,000 | -23.6% | 37,338 | -28.5% | 0.16% | -23.4% |
Q2 2019 | $4,288,000 | +8.9% | 52,217 | +8.0% | 0.20% | +0.5% |
Q1 2019 | $3,938,000 | +30.8% | 48,337 | +6.0% | 0.20% | +10.9% |
Q4 2018 | $3,011,000 | -28.9% | 45,614 | -16.4% | 0.18% | -9.8% |
Q3 2018 | $4,233,000 | -55.6% | 54,585 | -57.6% | 0.20% | -38.4% |
Q2 2018 | $9,537,000 | +17.6% | 128,814 | +3.5% | 0.33% | +14.5% |
Q1 2018 | $8,113,000 | -3.4% | 124,426 | -4.0% | 0.29% | +1.4% |
Q4 2017 | $8,402,000 | -1.4% | 129,666 | -4.2% | 0.28% | -5.3% |
Q3 2017 | $8,520,000 | +1.1% | 135,416 | -2.5% | 0.30% | -4.1% |
Q2 2017 | $8,429,000 | +57.8% | 138,876 | +35.2% | 0.31% | +49.5% |
Q1 2017 | $5,340,000 | +16.1% | 102,706 | -0.7% | 0.21% | +8.2% |
Q4 2016 | $4,598,000 | -9.9% | 103,381 | -3.3% | 0.19% | -15.7% |
Q3 2016 | $5,101,000 | -12.5% | 106,920 | -16.9% | 0.23% | -11.9% |
Q2 2016 | $5,830,000 | +69.6% | 128,704 | +73.7% | 0.26% | +66.2% |
Q1 2016 | $3,438,000 | +736.5% | 74,111 | +589.1% | 0.16% | +503.8% |
Q4 2015 | $411,000 | +245.4% | 10,755 | +209.2% | 0.03% | +116.7% |
Q3 2015 | $119,000 | -95.5% | 3,478 | -90.7% | 0.01% | -94.3% |
Q2 2015 | $2,625,000 | – | 37,266 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |